0001708138-21-000068.txt : 20210831 0001708138-21-000068.hdr.sgml : 20210831 20210831160300 ACCESSION NUMBER: 0001708138-21-000068 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210827 FILED AS OF DATE: 20210831 DATE AS OF CHANGE: 20210831 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: POON CHRISTINE A CENTRAL INDEX KEY: 0001189014 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 211227022 MAIL ADDRESS: STREET 1: C/O JOHNSON & JOHNSON STREET 2: ONE JOHNSON PLAZA CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2021-08-27 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001189014 POON CHRISTINE A 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 0 0 0 Common Stock 2021-08-27 4 M 0 15000 57.11 A 16681 D Common Stock 2021-08-27 4 S 0 100 662.62 D 16581 D Common Stock 2021-08-27 4 S 0 2260 663.51 D 14321 D Common Stock 2021-08-27 4 S 0 700 664.42 D 13621 D Common Stock 2021-08-27 4 S 0 538 665.33 D 13083 D Common Stock 2021-08-27 4 S 0 1118 666.7 D 11965 D Common Stock 2021-08-27 4 S 0 2150 667.37 D 9815 D Common Stock 2021-08-27 4 S 0 603 668.33 D 9212 D Common Stock 2021-08-27 4 S 0 2235 669.59 D 6977 D Common Stock 2021-08-27 4 S 0 3447 670.48 D 3530 D Common Stock 2021-08-27 4 S 0 1737 671.49 D 1793 D Common Stock 2021-08-27 4 S 0 112 672.27 D 1681 D Non-Qualified Stock Option (right to buy) 57.11 2021-08-27 4 M 0 15000 0.0 D 2022-01-03 Common Stock 15000 0 D Represents volume-weighted average price of sales of 2,260 shares of Company stock on August 27, 2021 at prices ranging from $663.11 to $663.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price. Represents volume-weighted average price of sales of 700 shares of Company stock on August 27, 2021 at prices ranging from $664.00 to $664.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price. Represents volume-weighted average price of sales of 538 shares of Company stock on August 27, 2021 at prices ranging from $665.07 to $665.54. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price. Represents volume-weighted average price of sales of 1,118 shares of Company stock on August 27, 2021 at prices ranging from $666.39 to $666.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price. Represents volume-weighted average price of sales of 2,150 shares of Company stock on August 27, 2021 at prices ranging from $667.01 to $667.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price. Represents volume-weighted average price of sales of 603 shares of Company stock on August 27, 2021 at prices ranging from $668.04 to $668.64. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price. Represents volume-weighted average price of sales of 2,235 shares of Company stock on August 27, 2021 at prices ranging from $669.17 to $669.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price. Represents volume-weighted average price of sales of 3,447 shares of Company stock on August 27, 2021 at prices ranging from $670.01 to $670.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price. Represents volume-weighted average price of sales of 1,737 shares of Company stock on August 27, 2021 at prices ranging from $671.00 to $671.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price. Represents volume-weighted average price of sales of 112 shares of Company stock on August 27, 2021 at prices ranging from $672.27 to $672.32. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price. The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. /s/**Christine A. Poon 2021-08-31